WHO ICTRP trial
An open-label, randomised, comparative, multi-centre study of the immunogenicity…
EUCTR2006-005445-11-FI · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2006-005445-11-FI |
|---|---|
| Public title | An open-label, randomised, comparative, multi-centre study of the immunogenicity and safety of the concomitant use of a live pentavalent rotavirus vaccine (RotaTeq®) and a meningococcal group C conjugate (MCC) vaccine in healthy infants |
| Scientific title | An open-label, randomised, comparative, multi-centre study of the immunogenicity and safety of the concomitant use of a live pentavalent rotavirus vaccine (RotaTeq®) and a meningococcal group C conjugate (MCC) vaccine in healthy infants |
| Primary sponsor | Sanofi Pasteur MSD S.N.C. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Finland |
| Conditions | RotaTeq® is indicated for the active immunisation of infants from age of 6 weeks for prevention of gastroenteritis due to rotavirus infection. NeisVac-C® is indicated for active immunisation of children from 2 months of age for the… |
| Interventions | Trade Name: RotaTeq Pharmaceutical Form: Oral solution Other descriptive name: rotavirus serotype G1 Concentration type: not less then Concentration number: 2.2x10(6)-IU (Infect Units) Other descriptive name: rotavirus serotype G2… |
| Registration date | Aug 11, 2006 |
| Secondary IDs | S06-ROT-304 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: